Low-dose carbon monoxide may explain the paradoxical reduced risk of Parkinson’s disease among smokers

“New research in lab models indicates that low doses of carbon monoxide—comparable to that experienced by smokers —protected against neurodegeneration and prevented the accumulation of a key PD-associated protein in the brain.”

Low-dose carbon monoxide may explain the paradoxical reduced risk of Parkinson’s disease among smokers (massgeneral.org)